Invizyne Technologies Selected for $2 Million Project to Advance Sustainable Aviation Fuel Capabilities
19 nov. 2024 09h05 HE
|
Invizyne Technologies, Inc.
Monrovia, CA, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Today, Invizyne Technologies, Inc., (NASDAQ: IZTC) ("Invizyne"), a leading designer of cell-free, enzyme-based biomanufacturing systems to produce...
Invizyne Technologies Announces Closing of Initial Public Offering
14 nov. 2024 16h05 HE
|
Invizyne Technologies, Inc.
Monrovia, CA, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and...
Invizyne’s Nasdaq IPO Marks New Era of Biomanufacturing
13 nov. 2024 16h05 HE
|
Invizyne Technologies, Inc.
Monrovia, CA, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Today, Invizyne Technologies, Inc., (NASDAQ:IZTC) ("Invizyne"), a leading designer of cell-free, enzyme-based biomanufacturing systems to produce...
Invizyne Technologies Begins Trading on NASDAQ
13 nov. 2024 09h05 HE
|
Invizyne Technologies, Inc.
Monrovia, CA, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and...
Invizyne Technologies to Begin Trading on NASDAQ on November 13, 2024
12 nov. 2024 10h52 HE
|
Invizyne Technologies, Inc.
Monrovia, CA, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and...
Invizyne Technologies Announces Pricing of $15 Million Initial Public Offering
11 nov. 2024 16h05 HE
|
Invizyne Technologies, Inc.
Monrovia, CA, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and...
Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
07 mai 2024 13h52 HE
|
Invizyne Technologies, Inc.
Michael Heltzen appointed as CEO bringing 20 years of global commercial leadership experience and a track record of successful launches and exits Additional industry veterans join in...
Invizyne Technologies Announces Filing of Registration Statement for Proposed Offering and Listing on Nasdaq
12 févr. 2024 08h00 HE
|
Invizyne Technologies, Inc.
Monrovia, CA, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of enzyme-based biomanufacturing systems – and a subsidiary of MDB Capital Holdings, LLC,...
Michael Burns Joins Invizyne as Executive Vice President of Energy Transition
08 nov. 2023 16h05 HE
|
Invizyne Technologies, Inc.
Monrovia, CA, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of enzyme-based biomanufacturing systems – and a subsidiary of MDB Capital Holdings, LLC,...
Invizyne Selected by Shell GameChanger Accelerator Powered by NREL for Sixth Cohort
17 oct. 2023 10h00 HE
|
Invizyne Technologies, Inc.
Monrovia, CA, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of enzyme-based biomanufacturing systems – and a subsidiary of MDB Capital Holdings, LLC,...